Global Feline Atopic Dermatitis Drug Market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The market is driven by factors such as increasing prevalence of feline atopic dermatitis and rising demand for natural products.
Corticosteroids are the most commonly used drugs in the treatment of feline atopic dermatitis, accounting for over 50% share in terms of value and volume in 2018. Antihistamines are also widely used drugs for treating feline atopic dermatitis, with a share of over 30%. Antibiotics are also used as an adjunct therapy to treat secondary bacterial infections associated with feline atopic dermatitis, which account for about 10% share in terms of value and volume in 2018.
Some Of The Growth Factors Of This Market:
- Increasing awareness about feline atopic dermatitis among pet owners and veterinarians is also expected to fuel the growth of this market over the forecast period.
- The rising demand for natural products for treatment purposes will also drive this market over the forecast period as these products are considered safer than conventional drugs with fewer side effects.
Industry Growth Insights published a new data on “Feline Atopic Dermatitis Drug Market”. The research report is titled “Feline Atopic Dermatitis Drug Market research by Types (Corticosteroids, Antihistamines, Antibiotics), By Applications (Veterinary Pharmacy, Retail Pharmacy, Online Pharmacy), By Players/Companies Bausch Health Companies, Bayer, Pfizer, Novartis, Sanofi, Eli Lily, Bristol-Myers Squibb, C. H. Boehringer Sohn”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Feline Atopic Dermatitis Drug Market Research Report
By Type
Corticosteroids, Antihistamines, Antibiotics
By Application
Veterinary Pharmacy, Retail Pharmacy, Online Pharmacy
By Companies
Bausch Health Companies, Bayer, Pfizer, Novartis, Sanofi, Eli Lily, Bristol-Myers Squibb, C. H. Boehringer Sohn
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Feline Atopic Dermatitis Drug Market Report Segments:
The global Feline Atopic Dermatitis Drug market is segmented on the basis of:
Types
Corticosteroids, Antihistamines, Antibiotics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Pharmacy, Retail Pharmacy, Online Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bausch Health Companies
- Bayer
- Pfizer
- Novartis
- Sanofi
- Eli Lily
- Bristol-Myers Squibb
- C. H. Boehringer Sohn
Highlights of The Feline Atopic Dermatitis Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Corticosteroids
- Antihistamines
- Antibiotics
- By Application:
- Veterinary Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Feline Atopic Dermatitis Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Feline atopic dermatitis (FA) is a skin condition in cats that causes inflammation and itching. Drugs used to treat FA include topical corticosteroids, antihistamines, and immunosuppressants.
Some of the key players operating in the feline atopic dermatitis drug market are Bausch Health Companies, Bayer, Pfizer, Novartis, Sanofi, Eli Lily, Bristol-Myers Squibb, C. H. Boehringer Sohn.
The feline atopic dermatitis drug market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Feline Atopic Dermatitis Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Feline Atopic Dermatitis Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Feline Atopic Dermatitis Drug Market - Supply Chain
4.5. Global Feline Atopic Dermatitis Drug Market Forecast
4.5.1. Feline Atopic Dermatitis Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Feline Atopic Dermatitis Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Feline Atopic Dermatitis Drug Market Absolute $ Opportunity
5. Global Feline Atopic Dermatitis Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Type
5.3.1. Corticosteroids
5.3.2. Antihistamines
5.3.3. Antibiotics
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Feline Atopic Dermatitis Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Application
6.3.1. Veterinary Pharmacy
6.3.2. Retail Pharmacy
6.3.3. Online Pharmacy
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Feline Atopic Dermatitis Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Feline Atopic Dermatitis Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Feline Atopic Dermatitis Drug Demand Share Forecast, 2019-2026
9. North America Feline Atopic Dermatitis Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Application
9.4.1. Veterinary Pharmacy
9.4.2. Retail Pharmacy
9.4.3. Online Pharmacy
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Type
9.7.1. Corticosteroids
9.7.2. Antihistamines
9.7.3. Antibiotics
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Feline Atopic Dermatitis Drug Demand Share Forecast, 2019-2026
10. Latin America Feline Atopic Dermatitis Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Application
10.4.1. Veterinary Pharmacy
10.4.2. Retail Pharmacy
10.4.3. Online Pharmacy
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Type
10.7.1. Corticosteroids
10.7.2. Antihistamines
10.7.3. Antibiotics
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Feline Atopic Dermatitis Drug Demand Share Forecast, 2019-2026
11. Europe Feline Atopic Dermatitis Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Application
11.4.1. Veterinary Pharmacy
11.4.2. Retail Pharmacy
11.4.3. Online Pharmacy
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Type
11.7.1. Corticosteroids
11.7.2. Antihistamines
11.7.3. ntibiotics
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Feline Atopic Dermatitis Drug Demand Share, 2019-2026
12. Asia Pacific Feline Atopic Dermatitis Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Application
12.4.1. Veterinary Pharmacy
12.4.2. Retail Pharmacy
12.4.3. Online Pharmacy
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Type
12.7.1. Corticosteroids
12.7.2. Antihistamines
12.7.3. Antibiotics
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Feline Atopic Dermatitis Drug Demand Share, 2019-2026
13. Middle East & Africa Feline Atopic Dermatitis Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Application
13.4.1. Veterinary Pharmacy
13.4.2. Retail Pharmacy
13.4.3. Online Pharmacy
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Feline Atopic Dermatitis Drug Market Size and Volume Forecast by Type
13.7.1. Corticosteroids
13.7.2. Antihistamines
13.7.3. Antibiotics
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Feline Atopic Dermatitis Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Feline Atopic Dermatitis Drug Market: Market Share Analysis
14.2. Feline Atopic Dermatitis Drug Distributors and Customers
14.3. Feline Atopic Dermatitis Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bausch Health Companies
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Novartis
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Sanofi
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Eli Lily
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bristol-Myers Squibb
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. C. H. Boehringer Sohn
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
